You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
景峯醫藥(000908.SZ)子公司貴州景誠製藥收到藥品再註冊批件
格隆匯 11-06 18:59

格隆匯11月6日丨景峯醫藥(000908.SZ)公佈,近日,公司子公司貴州景誠製藥有限公司收到貴州省藥品監督管理局核准簽發的一份《藥品再註冊批件》,藥品通用名稱為冰梔傷痛氣霧劑。

功能與主治清熱解毒涼血,活血化瘀止痛。用於跌打損傷,瘀血腫痛,亦可用於淺II度燒傷。

冰梔氣霧劑在當前市場的對標產品為雲南白藥氣霧劑,其市場銷量可觀,歷史銷售額突破10億元,該類產品市場需求旺盛,未來發展前景廣闊。冰梔氣霧劑再註冊批件的獲得確保了其未來持續生產和銷售,將對公司未來發展將產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account